CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.14B
1-Year Return
47.7%
This Quarter Return
-14.6%
1 Year Return
+47.7%
3 Year Return
+76.82%
5 Year Return
+185.43%
10 Year Return
+401.35%
AUM
$798M
AUM Growth
-$229M
(-22%)
Cap. Flow
-$79M
Cap. Flow
% of AUM
-9.89%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
782
New
308
Increased
96
Reduced
86
Closed
245
Top Buys
| 1 |
Valaris
VAL
|
+$19.1M |
| 2 |
Moderna
MRNA
|
+$9.63M |
| 3 |
T-Mobile US
TMUS
|
+$9.3M |
| 4 |
iShares Silver Trust
SLV
|
+$8.25M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$6.3M |
Top Sells
| 1 |
Tesla
TSLA
|
+$107M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$32.3M |
| 3 |
Microsoft
MSFT
|
+$20.8M |
| 4 |
Aptiv
APTV
|
+$19.8M |
| 5 |
Amazon
AMZN
|
+$12.7M |
Sector Composition
| 1 | Healthcare | 30.05% |
| 2 | Consumer Discretionary | 15.88% |
| 3 | Materials | 15.73% |
| 4 | Industrials | 6.57% |
| 5 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
CSX Corp
CSX
$59.7B
| $635K | 0.06% |
+21,864
| New | +$635K |
|
202
First American
FAF
$6.67B
| $629K | 0.06% |
+11,889
| New | +$629K |
|
203
Intuitive Surgical
ISRG
$161B
| $629K | 0.06% |
+3,133
| New | +$629K |
|
204
Rhythm Pharmaceuticals
RYTM
$6.68B
| $628K | 0.06% |
151,213
+110,105
| +268% | +$457K |
|
205
Xencor
XNCR
$597M
| $627K | 0.06% |
22,896
-5,276
| -19% | -$144K |
|
206
Bristol-Myers Squibb
BMY
$96.3B
| $622K | 0.06% |
+8,082
| New | +$622K |
|
207
News Corp Class A
NWSA
$16.2B
| $620K | 0.06% |
+39,804
| New | +$620K |
|
208
Align Technology
ALGN
$9.66B
| $619K | 0.06% |
2,616
+1,230
| +89% | +$291K |
|
209
Manhattan Associates
MANH
$12.9B
| $618K | 0.06% |
5,393
-393
| -7% | -$45K |
|
210
Abbott
ABT
$223B
| $616K | 0.06% |
+5,669
| New | +$616K |
|
211
Anika Therapeutics
ANIK
$124M
| $609K | 0.06% |
+27,267
| New | +$609K |
|
212
Fortune Brands Innovations
FBIN
$7.05B
| $606K | 0.06% |
+11,846
| New | +$606K |
|
213
Brighthouse Financial
BHF
$2.8B
| $601K | 0.06% |
14,660
-17,357
| -54% | -$712K |
|
214
Allegion
ALLE
$14.6B
| $598K | 0.06% |
+6,104
| New | +$598K |
|
215
Comcast
CMCSA
$123B
| $598K | 0.06% |
+15,248
| New | +$598K |
|
|
SAGE
216
DELISTED
Sage Therapeutics
SAGE
| $595K | 0.06% |
+18,426
| New | +$595K |
|
217
Protolabs
PRLB
$1.17B
| $592K | 0.06% |
12,372
+1,709
| +16% | +$81.8K |
|
218
Quaker Houghton
KWR
$2.42B
| $589K | 0.06% |
+3,942
| New | +$589K |
|
|
ICPT
219
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $589K | 0.06% |
42,653
| – | – |
|
220
Capital One
COF
$142B
| $586K | 0.06% |
5,624
-353
| -6% | -$36.8K |
|
221
Veeva Systems
VEEV
$44.8B
| $584K | 0.06% |
2,949
-3,202
| -52% | -$634K |
|
222
Donaldson
DCI
$9.34B
| $583K | 0.06% |
12,112
-5,149
| -30% | -$248K |
|
223
McCormick & Company Non-Voting
MKC
$18.4B
| $579K | 0.06% |
+6,954
| New | +$579K |
|
224
ASGN Inc
ASGN
$2.25B
| $578K | 0.06% |
+6,405
| New | +$578K |
|
|
KNDI
225
Kandi Technologies Group
KNDI
$113M
| $578K | 0.06% |
240,952
+39,429
| +20% | +$94.6K |
|